Kamada (KMDA) Assets Average (2013 - 2026)
Kamada's (KMDA) quarterly Assets Average came in at $380.9 million in Q1 2026, up 1.92% YoY from $373.7 million in Q1 2025, and up 0.77% on a QoQ basis from $378.0 million in Q4 2025.
Kamada (KMDA) Assets Average (2013 - 2026) Analysis & Trends
Kamada (KMDA) has 11 years of Assets Average data on file, last reported at $380.9 million in Q1 2026.
- Quarterly Assets Average rose 1.92% year-over-year to $380.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $380.9 million (up 1.92% YoY) and the FY2025 annual result came in at $375.5 million, up 3.27% from the prior year.
- Assets Average rose to $380.9 million in Q1 2026, from $378.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $171.8 billion in Q1 2024 to a low of $303.6 million in Q2 2022.
- A 5-year average of $77.7 billion and a median of $380.9 million in 2026 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average jumped 73810.4% — and 2024, when it plunged 99.79%.
- Tracing KMDA's Assets Average over 5 years: stood at $160.0 billion in 2022, then gained by 5.45% to $168.7 billion in 2023, then plunged by 99.79% to $361.7 million in 2024, then grew by 4.49% to $378.0 million in 2025, then rose by 0.77% to $380.9 million in 2026.
- The last three Assets Average figures came in at $380.9 million (Q1 2026), $378.0 million (Q4 2025), and $372.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Kamada | 466.36 Mn | 436.89 Mn | 22.47 Mn | 383.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 383.09 Mn |
| Mar 31, 2026 | 380.87 Mn |
| Dec 31, 2025 | 377.96 Mn |
| Sep 30, 2025 | 372.69 Mn |
| Jun 30, 2025 | 371.64 Mn |
| Mar 31, 2025 | 373.68 Mn |
| Dec 31, 2024 | 361.73 Mn |
| Sep 30, 2024 | 351.12 Mn |
| Jun 30, 2024 | 171.76 Bn |
| Mar 31, 2024 | 171.76 Bn |
| Dec 31, 2023 | 168.71 Bn |
| Sep 30, 2023 | 168.69 Bn |
| Jun 30, 2023 | 158.55 Bn |
| Mar 31, 2023 | 158.56 Bn |
| Dec 31, 2022 | 159.98 Bn |
| Sep 30, 2022 | 159.97 Bn |
| Jun 30, 2022 | 303.62 Mn |
| Mar 31, 2022 | 310.88 Mn |
| Dec 31, 2021 | 267.60 Mn |
| Sep 30, 2021 | 216.44 Mn |